primary%20open-angle%20glaucoma
PRIMARY OPEN-ANGLE GLAUCOMA
Primary open-angle glaucoma (POAG) is a chronic, progressive, usually bilateral disease of the eye with an insidious onset.
It is most often characterized by optic nerve damage, defects in the retinal fiber layer and subsequent visual field loss in the absence of underlying ocular disease or congenital abnormalities.
It is generally asymptomatic until it has caused a significant loss of visual field.
Occasionally, patients with very high intraocular pressure may complain of nonspecific headache, discomfort, intermittent blurring of vision or even halos caused by corneal edema.

Primary%20open-angle%20glaucoma Signs and Symptoms

Introduction

Ocular Hypertension (OH)

  • Refers to intaocular pressure (IOP) >21 mmHg or IOP that is >2-3 standard deviations from the normal population mean, in the absence of optic nerve damage or visual field defects
  • Represents a major risk for future development of primary open-angle glaucoma (POAG)

Definition

  • Primary open-angle glaucoma (POAG) is a chronic, progressive, usually bilateral disease with an insidious onset
  • Most often characterized by optic nerve damage, defects in the retinal fiber layer and subsequent visual field loss in the absence of underlying ocular disease or congenital abnormalities
    • Usually of adult onset with open normal appearance of anterior chamber angles

Signs and Symptoms

  • It is generally asymptomatic until it has caused a significant loss of visual field
    • Visual acuity is lost when there is central visual field loss which is a late manifestation of the disease
  • Occasionally, patients with very high intraocular pressure (IOP) may complain of nonspecific headache, discomfort, intermittent blurring of vision or even halos caused by corneal edema
    • Although a high IOP is associated with open-angle glaucoma, it is not necessary for the diagnosis and is considered a “risk factor”; many patients with primary open-angle glaucoma (POAG) do not have increased IOP and not all patients with increased IOP will develop a glaucoma

Risk Factors

  • Age - incidence of primary open-angle glaucoma (POAG) increases with age
  • Race - estimated prevalence is approximately 3 times greater among African Americans, Hispanics/Latino and even higher among Afro-Caribbeans
  • Family history - risk is increased in those with an affected first-degree relative (parent or sibling, with the latter having the strongest association)
  • Elevated intraocular pressure (IOP)
    • Currently, there is no evidence of a threshold IOP for the onset of POAG although risk of developing glaucoma is 12 times greater for those with IOP >26 mmHg
    • Traditional definition of a normal IOP is 2 standard deviations above normality (21 mmHg)
  • Thin central cornea increases risk for developing glaucoma
  • Pseudoexfoliation
  • Myopia
  • Low ocular perfusion pressures
  • Local/ocular
    • Optic disc hemorrhage
    • Peripapillary atrophy
    • Larger cup-to-disc ratio
  • Systemic
    • Cardiovascular disease
    • Hypertension
    • Type 2 diabetes mellitus
    • Hypothyroidism
    • Migraine headache, peripheral vasospasm
    • Obstructive sleep apnea
Editor's Recommendations
Most Read Articles
23 hours ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
30 Jun 2020
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Christina Lau, 5 days ago

Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.